There has been increased interest in the clinical laboratory to develop comprehensive LC-MS/MS assays for urine drug testing, with fifty or more drugs and metabolites from multiple drug classes in a single method. These panels can increase throughput and improve laboratory efficiency, but also create many challenges.
Chemists and technologists, laboratory supervisors and managers, medical directors and R&D scientists in laboratories who develop, validate, or perform assays for urine drug testing.
This webinar was recorded on Thursday 9th March 2017
Stephanie J. Marin, Senior Applications Chemist at Biotage.
Stephanie J. Marin received her Ph.D. in chemistry from Arizona State University. She has expertise in sample preparation, liquid chromatography, and mass spectrometry. She has over 10 years of experience developing and validating clinical assays from her tenure at the ARUP Institute for Clinical and Experimental Pathology. She is the author of over 30 peer reviewed publications and book chapters and over 80 abstracts presented at national meetings.
New Peptide Synthesis Workflow Brochure
Extraction of Plasma Catecholamines and Metanephrines Using EVOLUTE® EXPRESS WCX SPE Prior to LC-MS/MS Analysis
New Second Generation Solvent Evaporators from Biotage
Extraction of Tobacco-Specific Nitrosamines (TSNAs) from Urine Using ISOLUTE® SLE+ Prior to UPLC/MS/MS Analysis
How to Make up to 576 Peptides in One Run